S&P Equity Research downgrades Edwards Lifesciences (NYSE: EW) from Buy to Hold.

S&P analyst, R. Gold, says, "Q4 operating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE